Stay updated with breaking news from Eric Vivier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“What are you going to do with that degree? You are never going to make any money. Do you really like to read? Are you sure? I bet your schedule is so easy. Did I mention you are not going to make any money?” I have heard some variation of these little quips and questions...
“What are you going to do with that degree? You are never going to make any money. Do you really like to read? Are you sure? I bet your schedule
Four distinguished immunologists have been awarded one of the most generously funded research grants from the EU: the ERC Synergy Grant.
Kepler Capital analyst Justine Telliez maintained a Hold rating on Innate Pharma SA (IPHYF – Research Report) on June 16 and set a price ...
Clarus Therapeutics (OTCMKTS:CRXTQ – Get Rating) and Innate Pharma (OTCMKTS:IPHYF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Volatility and Risk Clarus Therapeutics has a beta of […]